Cancer types that showed CR or PR in anti-CD47 mAb studies included colorectal (n=2), ovarian (n=2), and endometrial (n=1) cancers and adenocarcinoma of the finger (n=1); in selective SIRPα blocker studies, these included HER2+ gastroesophageal (n=13), head and neck (n=9), colorectal (n=1), endometrial (n=1), non-small cell lung (n=1), and hepatocellular (n=1) cancers. The gene discussed is CD47; the disease is cancer.